Correlation Between Zoetis and Cardiff Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zoetis and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Cardiff Oncology, you can compare the effects of market volatilities on Zoetis and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Cardiff Oncology.

Diversification Opportunities for Zoetis and Cardiff Oncology

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Zoetis and Cardiff is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Zoetis i.e., Zoetis and Cardiff Oncology go up and down completely randomly.

Pair Corralation between Zoetis and Cardiff Oncology

Considering the 90-day investment horizon Zoetis Inc is expected to generate 0.16 times more return on investment than Cardiff Oncology. However, Zoetis Inc is 6.1 times less risky than Cardiff Oncology. It trades about 0.01 of its potential returns per unit of risk. Cardiff Oncology is currently generating about -0.2 per unit of risk. If you would invest  17,518  in Zoetis Inc on September 3, 2024 and sell it today you would earn a total of  7.00  from holding Zoetis Inc or generate 0.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Zoetis Inc  vs.  Cardiff Oncology

 Performance 
       Timeline  
Zoetis Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zoetis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Zoetis is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Cardiff Oncology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiff Oncology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent fundamental indicators, Cardiff Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Zoetis and Cardiff Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zoetis and Cardiff Oncology

The main advantage of trading using opposite Zoetis and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.
The idea behind Zoetis Inc and Cardiff Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like